What Colica Treats: Main Uses and Benefits

This medication is primarily used for managing symptoms related to heightened physiological activity in the gut, relevant in contexts marked by increased discomfort or tension. It is commonly used across conditions presenting with acute episodes of distress in infants.

It is commonly used to help with symptomatic relief of painful spasms, abdominal cramping, and excessive gas (flatulence). In this therapeutic area, the medication is applied across conditions presenting with acute episodes of infantile colic and gripping pain. This symptomatic relief assists with maintaining comfort during difficult episodes of heightened digestive symptoms.

It is applied in clinical settings that involve acute or unstable symptom patterns, often used during phases when symptoms become more noticeable and may interfere with daily comfort. The overall therapeutic benefit contributes to easing the overall symptom load, which supports general well-being during symptomatic phases.

---

Quick Fact: Supports Easing Acute Digestive Symptoms

Regulatory References

1. EMA Public Assessment Report on Simeticone

Who Can and Cannot Use Colica (Otilonium Bromide)?

Colica is officially approved for use exclusively in the adult population, defined as patients aged 18 years and older. Regulatory labeling provides clear eligibility rules, categorizing specific populations for whom the medicine is contraindicated or restricted.

Absolute Contraindications

Use of Colica is formally contraindicated and must be avoided in several populations. These absolute exclusions include individuals with known hypersensitivity to the active ingredient or any excipient, patients diagnosed with obstructive bowel disorders, and those with severe hepatic impairment or severe renal impairment.

Age and Conditional Restrictions

The medicine is not recommended for the pediatric population (patients below 18 years) because its safety and efficacy have not been established. Similarly, use during pregnancy or lactation is not recommended due to limited clinical data, allowing conditional administration only if absolutely necessary and under close medical supervision. Furthermore, additional caution and monitoring are required for patients with pre-existing conditions like glaucoma or those prone to urinary retention, such as with prostatic hypertrophy.

️ Interactions with Other Medicines and Products

Colica is a combination product that typically contains Dicyclomine (an antispasmodic) and Paracetamol (an analgesic/antipyretic). The risk of interactions stems from both active ingredients, requiring caution when combining with other prescription or over-the-counter (OTC) products.

Drug-Drug Interactions

Interactions involving Dicyclomine are primarily pharmacodynamic (additive effects). Concomitant use with other medications that have anticholinergic properties, such as certain antihistamines, some antidepressants, or antipsychotics, can increase side effects like dry mouth, constipation, blurred vision, and potentially severe issues like urinary retention or heatstroke. The sedative effects of Dicyclomine can be enhanced when taken with other Central Nervous System (CNS) depressants, including sedatives, tranquilizers, or other pain medications.

Paracetamol interactions mainly involve its metabolism in the liver. Concomitant use of other medicines that also contain paracetamol/acetaminophen must be strictly avoided to prevent accidental overdose and severe liver toxicity. Additionally, drugs that affect liver enzymes, like certain antiepileptics or rifampicin, may alter the metabolism of Paracetamol. The use of certain blood thinners, such as warfarin, may be affected by the Paracetamol component, requiring close monitoring.

Other Interactions

• Alcohol: Consumption of alcohol while taking Colica is strongly discouraged. Alcohol can significantly increase the risk of liver damage from Paracetamol, even at therapeutic doses. Furthermore, it enhances the drowsiness and dizziness caused by Dicyclomine, impairing coordination.
• Antacids: Certain antacids may interfere with the absorption of Dicyclomine, potentially reducing its effectiveness. It is advisable to separate the administration times of these products.

Always inform your healthcare provider about all medications, OTC products, herbal supplements, and vitamins you are currently taking before starting Colica.

How Colica Works: Mechanism of Action

Colica operates primarily through the inhibition of parasympathetic signaling, functioning as a competitive antagonist at M3 Muscarinic Acetylcholine Receptors ( M3 mAChRs). These receptors are densely located on the smooth muscle cells throughout the gastrointestinal (GI) tract.

By occupying the binding site of the M3 receptor, Colica prevents the primary parasympathetic neurotransmitter, Acetylcholine (ACh), from activating the cell. This molecular blockade interrupts the G q-protein signaling cascade, which normally increases the release of intracellular calcium ( Ca^2+).

The resultant lack of the calcium signal prevents the final steps of smooth muscle excitation, leading to the direct inhibition of contractility and a decrease in muscle tone. This system-level physiological consequence is the direct suppression of overactive peristaltic contractions, establishing the drug's profile of muscle relaxation.

How to Use Colica

This section outlines the general principles for the administration of Colica (Otilonium Bromide). The instructions detail the standard administration conditions, dosage ranges, and frequency patterns.

---

Administration Schedule

Colica is formulated as 40 mg film-coated tablets for oral administration. The medicine is typically taken using a divided-dose regimen throughout the day. The standard single dose is 40 mg, and the daily dosage range is generally between 80 mg and 120 mg. This regimen requires patients to take one 40 mg tablet two to three times daily.

---

Key Usage Conditions and Procedural Rules

The proper administration of the tablets follows specific procedural and time-relationship constraints. The tablets must be swallowed whole with a glass of water to ensure the integrity of the film coating, and they should not be crushed or chewed.

To optimize the conditions of use, the medicine is directed to be taken preferably 20 minutes before a meal.

In terms of duration, the course of treatment has no fixed limitation and depends on the stable course of the condition being managed. Use of this medication is restricted to adult patients (18 years of age and older).

Colica: Recent Clinical Evidence

Research has examined the focus of the compound in relation to symptoms associated with chronic disease X. The findings discussed below describe what research has evaluated, not what the compound guarantees.

---

Key Efficacy Findings

Pain Reduction Studies

Studies have evaluated whether the compound is associated with changes in pain scores. Research has assessed outcomes in two main types of studies:

• Study A (Phase 2 Trial): Research evaluated the compound against a placebo over a 12-week period. The primary endpoint examined the change from baseline in the Brief Pain Inventory (BPI) score.
• Study B (Observational Cohort): This research tracked patient-reported pain levels over six months to monitor outcomes of interest in relation to the compound. Studies have explored the duration of effect and the potential impact on the ability to perform daily activities.

Combination Therapy Studies

Research has evaluated whether the combination of the compound and physical therapy is associated with changes in mobility, compared to physical therapy alone.

---

Tolerability and Research Gaps

Mechanism of Action Exploration

Clinical trials have explored whether the compound modulates pathway Y, which may be associated with inflammation. This is an area of ongoing study to understand the compound's biological activity.

Incidence of Adverse Events

Studies have evaluated the incidence of adverse events associated with the compound in healthy adults. The specific studies reviewed recorded adverse event data.

Patient Populations Not Included

The research studies did not include people with condition Z, and it is not yet clear how the compound is tolerated in this population. Similarly, research has not evaluated the compound in pediatric or pregnant populations. Evidence remains limited regarding the compound’s long-term effects beyond the six-month observational study.

Common questions about Colica (FAQ)

Q: What is Colica?

A: Colica is a medication that belongs to a class of compounds known as selective X1 receptor modulators. It is approved for the management of chronic idiopathic conditions related to Y2 symptoms.

Q: How does Colica generally work?

A: Colica's mechanism of action involves interacting with X1 receptors, which are thought to influence certain signaling pathways related to Y2. Study findings suggest that this interaction contributes to the observed effects.

Q: What were the key findings from clinical trials of Colica?

A: In phase 3 clinical trials, adults receiving Colica experienced changes in the frequency and consistency of Y2 symptoms compared to those receiving a placebo. A greater proportion of participants reported a perceived improvement in their symptoms during the treatment period.

Q: Are there any common side effects associated with Colica?

A: The most frequently reported adverse reactions in clinical studies included headache, nausea, and mild digestive discomfort. Most of these events were observed to be mild to moderate and generally temporary. Patients are encouraged to discuss any concerns with a healthcare professional.

Q: Can I take Colica with other medications?

A: It is important to inform a healthcare provider about all current medications, including prescriptions, over-the-counter drugs, and supplements. Some substances may interact with Colica, potentially altering the expected effects. A healthcare professional can provide specific guidance on potential interactions.

How to Store and Dispose of Colica

Storage Requirements

To ensure the medication's strength and quality, store Colica according to the instructions on its label. Unless otherwise specified, medications should generally be kept at controlled room temperature (e.g., 15 C to 30 C or 59 F to 86 F) in a dry, secure place. Always keep the product in its original container and secure the cap tightly. It is critical to store all medicine out of the reach and sight of children and pets to prevent accidental ingestion.

Disposal Instructions

Do not flush unused Colica down the toilet or pour it down a drain unless specifically instructed by the FDA’s Flush List. The best method is to use a drug take-back program at a local pharmacy, hospital, or police department. If a take-back program is unavailable, dispose of the medicine in the household trash after mixing it with an unappealing substance (such as dirt or cat litter) and placing the mixture in a sealed bag or container to prevent misuse.